Gerber, Markus http://orcid.org/0000-0001-6140-8948
Ayekoé, Serge A.
Beckmann, Johanna
Bonfoh, Bassirou
Coulibaly, Jean T.
Daouda, Dao
du Randt, Rosa
Finda, Lina
Gall, Stefanie
Mollel, Getrud J.
Lang, Christin
Long, Kurt Z.
Ludyga, Sebastian
Masanja, Honorati
Müller, Ivan
Nqweniso, Siphesihle
Okumu, Fredros
Probst-Hensch, Nicole
Pühse, Uwe
Steinmann, Peter
Traoré, Sylvain G.
Walter, Cheryl
Utzinger, Jürg
Funding for this research was provided by:
Fondation Botnar (6071)
Article History
Received: 19 October 2018
Accepted: 5 November 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: Data assessment can only begin in a study country once approval from the required authorities has been received. Ethical approval has been obtained from the ‘Ethikkommission Nordwest- und Zentralschweiz’ in Switzerland (EKNZ, reference number: Req-2018-00608:). The intervention study has been registered in the ISRCTN registry (ExternalRef removed). The study protocol has been approved in Côte d’Ivoire by the Institutional Review Board of the Centre Suisse de Recherches Scientifiques en Côte d’Ivoire (CSRS; Abidjan, Côte d’Ivoire) and the Comité National d’Ethique et de la Recherche (CNER) (reference number: 100–18/MSHP/CVESVS-km). Approval has also been obtained in South Africa from the research ethics committee of the Nelson Mandela University in Port Elizabeth (reference number: H18-HEA-HMS-006) and the Department of Education of the Eastern Cape Province. Moreover, the study protocol has been approved by the responsible ethics committee in Tanzania (Ifakara Health Institute–Institutional Review Board (IHI-IRB), National Institute for Medical Research (NIMR)) and the Tanzania Food and Drugs Authority (TFDA). Oral assent will be sought from children, and written informed consent will be sought from the parents/guardians before the start of the data assessment.
: Not applicable. Our manuscripts will not contain the personal data of any individual.
: The authors declare that they have no competing interests.